The Technical Analyst
Item 9 Labs Corp. [INLB]
Exchange: PNK Industry: Medical Devices
Item 9 Labs Corp. Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $0.0002
America/New_York / 3 mai 2024 @ 15:28
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 0.0205 mill |
| EPS: | -0.330 |
| P/E: | 0 |
| Earnings Date: | May 20, 2024 |
| SharesOutstanding: | 102.36 mill |
| Avg Daily Volume: | 14.39 mill |
| RATING 2024-05-03 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Strong Buy | |
| P/E: | Sell | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 1/22 | 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE -11.58 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE -6.92 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0002 - 0.0002 ( +/- 0.00%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2021-12-14 | Kutscher Eric | Sell | 0 | Common Stock |
| 2021-12-14 | Taylor Lawrence X. Iii | Sell | 0 | Common Stock |
| 2020-02-04 | Bowden Douglas P | Buy | 0 | Common Stock |
| 2020-02-04 | Bowden Douglas P | Sell | 0 | Common Stock |
| 2020-03-23 | Bowden Douglas P | Buy | 1 100 000 | Convertible Promissory Note |
| INSIDER POWER |
|---|
| 0.00 |
| Last 53 transactions |
| Buy: 1 214 689 | Sell: 874 343 |
Forecast:
16:00 - $0.0002
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $0.0002 (0.00% ) |
| Volume | 0.0013 mill |
| Avg. Vol. | 14.39 mill |
| % of Avg. Vol | 0.0090 % |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For INLB
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
INLB
Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.
Latest Press Releases
2022-08-03 10:36:00 - Press Release
Item 9 Labs Corp. To Host Third Quarter Fiscal Year 2022 Earnings Call On August 16 At 8:30 A.m. Et
Phoenix , aug. 3, 2022 /prnewswire/ -- item 9 labs corp. (otcqx: inlb) (the "company")—a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products—announced today that it will host a conference call on tuesday august 16, 2022, to share financial results for the third quarter of fiscal year 2022, which ended june 30, 2022. the 10q will be filed on monday, august 15, 2022.
2022-04-05 09:17:00 - Press Release
Item 9 Labs Corp. To Present At Leading Investor Conferences In April
Vertically integrated cannabis dispensary franchisor and operator to share recent positive momentum for accelerated national growth in 2022 phoenix , april 5, 2022 /prnewswire/ -- item 9 labs corp. (otcqx: inlb) (the "company") – a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products – announced today that the company's executive team will be participating in multiple investor events in april. these events include: noble capital markets' 18th annual small & microcap investor conference (noblecon18), sequire's cannabis & psychedelic virtual conference and benzinga's spring cannabis capital conference.
2022-02-21 10:49:00 - Press Release
Unity Rd.'s Chief Franchise Officer To Present At International Franchise Association's 2022 Convention
Phoenix, feb. 21, 2022 /prnewswire/ -- unity rd., the first true vertically integrated cannabis dispensary franchise from item 9 labs corp. (otcqx: inlb), continues to establish itself as a rising trailblazer in franchising.
2022-01-25 15:48:00 - Press Release
Unity Rd.'s Vp Of Communications To Present At Youngconference
Phoenix, jan. 25, 2022 /prnewswire/ -- unity rd., the cannabis dispensary franchise from item 9 labs corp. (otcqx: inlb), continues to solidify their position as industry trailblazers.
2021-10-07 08:12:00 - Press Release
Item 9 Labs Corp. To Acquire Colorado Dispensary, Kickstarts National Acquisition Growth Plan
Phoenix, oct. 7, 2021 /prnewswire/ -- item 9 labs corp. (otcqx: inlb) (the "company")—a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products—today announced it has signed an asset purchase agreement ("apa") for an existing dispensary license and storefront in adams county, co. this will be the first corporate-owned shop under its cannabis dispensary franchise brand, unity rd.
Latest News
2022-08-16 11:53:06 - Seeking Alpha
Item 9 Labs Corp. (INLB) CEO Andrew Bowden on Q3 2022 Results - Earnings Call Transcript
Item 9 Labs Corp. (OTCQX:INLB) Q3 2022 Earnings Conference Call August 16, 2022 8:30 AM ET Company Participants Jason Assad - Investor Relations Andrew Bowden - Chief Executive Officer Bobby Mikkelsen - Chief Financial Officer Jason Assad [Abrupt Start] Joining me on today's call is our Chief Executive Officer, Andrew Bowden and our Chief Financial Officer, Bobby Mikkelson. Shortly before this call, we filed our Form 10-Q, a copy of which is available on the company's website at item9labscorp.com.
2022-08-15 21:04:06 - Zacks Investment Research
Item 9 Labs Corp. (INLB) Reports Q3 Loss, Misses Revenue Estimates
Item 9 Labs Corp. (INLB) delivered earnings and revenue surprises of -100% and 29.56%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
2022-08-03 10:36:00 - PRNewsWire
Item 9 Labs Corp. to Host Third Quarter Fiscal Year 2022 Earnings Call on August 16 at 8:30 a.m. ET
PHOENIX , Aug. 3, 2022 /PRNewswire/ -- Item 9 Labs Corp. (OTCQX: INLB) (the "Company")—a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products—announced today that it will host a conference call on Tuesday August 16, 2022, to share financial results for the third quarter of fiscal year 2022, which ended June 30, 2022. The 10Q will be filed on Monday, August 15, 2022.
2022-05-16 23:25:17 - Seeking Alpha
Item 9 Labs Corp. (INLB) CEO Andrew Bowden on Q2 2022 Results - Earnings Call Transcript
Item 9 Labs Corp. (OTCQX:INLB) Q2 2022 Earnings Conference Call May 16, 2022 4:30 PM ET Company Participants Jason Assad - Investor Relations Andrew Bowden - Chief Executive Officer Bobby Mikkelsen - Chief Financial Officer Conference Call Participants Jason Assad Hello, this is Jason Assad, Investor Relations with Item 9 Labs. Good afternoon, and welcome to Item 9 Labs Fiscal Q2 2022 Results Conference Call for the three months ended March 31, 2022.
2022-05-16 20:18:06 - Zacks Investment Research
Item 9 Labs Corp. (INLB) Reports Q2 Loss, Lags Revenue Estimates
Item 9 Labs Corp. (INLB) delivered earnings and revenue surprises of -33.33% and 9.07%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
2022-04-05 09:17:00 - PRNewsWire
Item 9 Labs Corp. to Present at Leading Investor Conferences in April
Vertically Integrated Cannabis Dispensary Franchisor and Operator to Share Recent Positive Momentum for Accelerated National Growth in 2022 PHOENIX , April 5, 2022 /PRNewswire/ -- Item 9 Labs Corp. (OTCQX: INLB) (the "Company") – a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products – announced today that the Company's executive team will be participating in multiple investor events in April. These events include: Noble Capital Markets' 18th Annual Small & Microcap Investor Conference (NobleCon18), Sequire's Cannabis & Psychedelic Virtual Conference and Benzinga's Spring Cannabis Capital Conference.
2022-02-21 10:49:00 - PRNewsWire
Unity Rd.'s Chief Franchise Officer to Present at International Franchise Association's 2022 Convention
PHOENIX, Feb. 21, 2022 /PRNewswire/ -- Unity Rd., the first true vertically integrated cannabis dispensary franchise from Item 9 Labs Corp. (OTCQX: INLB), continues to establish itself as a rising trailblazer in franchising.
2022-02-15 17:33:02 - Seeking Alpha
Item 9 Labs Corp. (INLB) CEO Andrew Bowden on Q1 2022 Results - Earnings Call Transcript
2022-01-25 15:48:00 - PRNewsWire
Unity Rd.'s VP of Communications to Present at YoungConference
PHOENIX, Jan. 25, 2022 /PRNewswire/ -- Unity Rd., the cannabis dispensary franchise from Item 9 Labs Corp. (OTCQX: INLB), continues to solidify their position as industry trailblazers.
2022-01-18 17:08:02 - Seeking Alpha
Item 9 Labs Corp.'s (INLB) CEO Andrew Bowden on Q4 2021 Results - Earnings Call Transcript
Item 9 Labs Corp.'s (INLB) CEO Andrew Bowden on Q4 2021 Results - Earnings Call Transcript